TAF4-CDH4 Fusion FISH Probe
The TAF4-CDH4 Fusion FISH Probe is used to confirm a fusion of the TAF4 and CDH4 genes. The fusion of the TAF4 and CDH4 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
TAF4-CDH4-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-RERE | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-REOR | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-REGO | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-REGR | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-REAQ | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-ORRE | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-OROR | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-ORGO | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-ORAQ | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GORE | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GOOR | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GOGO | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GOGR | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GOAQ | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GRRE | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GROR | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GRGO | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GRGR | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-GRAQ | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-AQRE | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-AQOR | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-AQGO | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-AQGR | 20 (40 μL) | 200 μL | ||
TAF4-CDH4-20-AQAQ | 20 (40 μL) | 200 μL |
CDH4 Gene Summary
This gene is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium-dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Based on studies in chicken and mouse, this cadherin is thought to play an important role during brain segmentation and neuronal outgrowth. In addition, a role in kidney and muscle development is indicated. Of particular interest are studies showing stable cis-heterodimers of cadherins 2 and 4 in cotransfected cell lines. Previously thought to interact in an exclusively homophilic manner, this is the first evidence of cadherin heterodimerization. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
Gene Name: Cadherin 4
Chromosome: CHR20: 59827558 -60512299
Locus: 20q13.33
TAF4 Gene Summary
Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that has been shown to potentiate transcriptional activation by retinoic acid, thyroid hormone and vitamin D3 receptors. In addition, this subunit interacts with the transcription factor CREB, which has a glutamine-rich activation domain, and binds to other proteins containing glutamine-rich regions. Aberrant binding to this subunit by proteins with expanded polyglutamine regions has been suggested as one of the pathogenetic mechanisms underlying a group of neurodegenerative disorders referred to as polyglutamine diseases. [provided by RefSeq, Jul 2008]
Gene Name: TATA-box Binding Protein Associated Factor 4
Chromosome: CHR20: 60549853 -60640866
Locus: 20q13.33
Gene Diseases
The TAF4 CDH4 Fusion has been associated with the following diseases:
Disease Name |
---|
Breast Invasive Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|